Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-22

Clinical Trial Update: Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety, tolerability, and pharmacokinetics of once-weekly zicronapine in adults with schizophrenia has completed and poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zicronapine

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED | Results posted: 2016-03-22